HCAT — HEALTH CATALYST INC

Ownership history in AMH Equity Ltd  ·  3 quarters on record

This page tracks every 13F SEC filing in which AMH Equity Ltd reported a position in HEALTH CATALYST INC (HCAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.34% (2025 Q3)
Avg. % of fund
2.06%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 660,000 +232,851 +54.5% 2.34% $1.9M $2.85
2025 Q2 ADDED 427,149 +174,649 +69.2% 2.12% $1.6M $3.77
2025 Q1 INITIATED 252,500 — — 1.73% $1.1M $4.53
% of Fund (quarterly)    HCAT price (monthly, adj. close)

Other funds also holding HCAT

As of 2025 Q4 — sorted by position size

Whetstone Capital Advisors, LLC 3Y 7Y 2.8% First Light Asset Management, LLC 3Y 7Y 2.36% Nepsis Inc. 3Y 7Y 1.41% Palogic Value Management, L.P. 3Y 1.27% HighMark Wealth Management LLC 3Y 0.72% MARTIN & CO INC /TN/ 3Y 7Y 0.21% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.07% CVS HEALTH Corp 3Y 0.06% nVerses Capital, LLC 0.06% Williams & Novak, LLC 0.05%
← Back to AMH Equity Ltd Holdings